We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Red Wine May Shield Brain from Stroke Damage

By HospiMedica International staff writers
Posted on 05 May 2010
A new study has found that a compound found in the skins and seeds of red grapes may protect the brain from damage following a stroke.

Researchers at Johns Hopkins University (JHU: Baltimore, MD, USA) studied the effects of resveratrol--an enriched bioactive polyphenol found in red wine--in cultured mouse cortical neuronal cells. More...
The researcher found that the resveratrol selectively induced heme oxygenase 1 (HO1) in the cells in a dose- and time-dependent manner, providing neuroprotection from free radical or excitotoxicity damage. This protection was lost when the cells were treated with a protein synthesis or heme oxygenase inhibitor, suggesting that HO1 induction was at least partially required for resveratrol's prophylactic properties to take effect.

The researchers then fed study mice a single modest dose of resveratrol, and two hours later induced a stroke in an optimized ischemic-reperfusion stroke model. The researchers found that the resveratrol pretreatment protected the mice in a dose-dependent fashion. According to the researchers, the results suggest that the amount of resveratrol needed to provide the neuroprotective effect could be quite small, as the suspected beneficial mechanism is indirect; resveratrol and its metabolites may not be directly shielding brain cells from free radical damage, but could instead be prompting the cells to defend themselves. The study was published ahead of print on April 8, 2010, in Experimental Neurology.

"Our study adds to evidence that resveratrol can potentially build brain resistance to ischemic stroke. It's not likely that brain cells can have high enough local levels of resveratrol to be protective,” said lead author Sylvain Doré, Ph.D., and colleagues of the department of anesthesiology and critical care medicine. "The resveratrol is needed to jump-start this protective enzymatic system that is already present within the cells; even a small amount may be sufficient.”

Red wine has several purported health benefits, and moderate wine consumption has been linked to a lowered incidence of cardiovascular disease. This phenomenon has been named the French paradox, since despite diets high in butter, cheese, and other saturated fats, the French have a relatively low incidence of cardiovascular events, which some have attributed to the regular drinking of red wine.

While the concentration of resveratrol in wine seems too low to account for the French Paradox, an additional group of polyphenols, known as oligomeric procyanidins, could offer the greatest degree of protection to human blood-vessel cells. Tests with 165 types of wine have shown that these are found in greatest concentration in European red wines from certain areas, which correlates with longevity in those regions. The highest procyanidins are found in wines from the Tannat grape, grown in the Gers area of southwest France and in Uruguay.

Related Links:
Johns Hopkins University


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.